Tags: eosinophilic esophagitisprematurityallergic sensitizationallergyprescription
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | Lebrikizumab Wins FDA Approval for Eczema - 6 days ago FDA Approves First Oral Option for Eosinophilic Esophagitis - 7 months ago FDA OKs Maintenance Option for High-Risk Neuroblastoma - 9 months ago New Options Challenge Standard Treatments in EGFR-Mutant NSCLC - 11 months ago | |
2 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 7 days ago | |
3 | Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA | ||
4 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Study Confirms: No Great Options for Treating VEXAS - 4 months ago Novel Lupus Approach Yields Mixed Results in Early Trial - 7 months ago | |
5 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Novel Therapies in the Pipeline for Asthma Treatment - 6 months ago Biologics Offer New Options in Atopic Dermatitis - 10 months ago How and When to Escalate Treatment for Eczema - 10 months ago Future of Atopic Dermatitis Management - 10 months ago The Landscape of New Treatments for Eczema - 10 months ago Targeting Chronic Inflammation in Progressive MS - 10 months ago | |
6 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial - about 1 year ago | |
7 | Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area | ||
8 | Elise Reuter MedTech Dive Reporter @MedTechDive. Covers medical devices. | ||
9 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | ||
10 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois |